Quick verdict
9amHealth is the better pick for most patients on overall scoring. 9amHealth treats GLP-1 as one tool inside a broader cardiometabolic program. Strong employer and insurance relationships, branded-first medication strategy, labs included. Best fit for patients with comorbidities, not pure weight-loss buyers.
That said, Found wins on specific dimensions. Found has the broadest medication catalog of any program here, including off-label tirzepatide and orforglipron access through their Foundayo program. The 6-month non-refundable subscription is the catch.
Side-by-side
| Found | 9amHealth | |
|---|---|---|
| Starts from | $99/mo (+ med separate) | $25/mo (+ med separate) |
| Lock-in | 6-month lock-in | Month-to-month |
| Time to prescription | 5 days | 5 days |
| Consultation type | Asynchronous | Synchronous |
| Affiliate network | Impact | Direct |
Score by dimension
Five dimensions, ten points each. The winner of each dimension is highlighted.
| Found | 9amHealth | |
|---|---|---|
| Pricing transparency | 6/10 | 7/10 |
| Cancellation terms | 3/10 | 8/10 |
| Onboarding experience | 8/10 | 6/10 |
| Medication options | 9/10 | 7/10 |
| Member outcomes | 5/10 | 8/10 |
When to choose Found
Patients whose obesity medicine clinician has flagged a non-standard medication path (multiple drug classes, off-label combinations, or 503A-compounded options that other programs have exited).
When to choose 9amHealth
Patients with diabetes, prediabetes, or cardiovascular risk who want GLP-1 inside comprehensive metabolic care.
FAQ
Is Found cheaper than 9amHealth?
Can I switch from Found to 9amHealth mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart →